JP2002518051A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002518051A5 JP2002518051A5 JP2000556036A JP2000556036A JP2002518051A5 JP 2002518051 A5 JP2002518051 A5 JP 2002518051A5 JP 2000556036 A JP2000556036 A JP 2000556036A JP 2000556036 A JP2000556036 A JP 2000556036A JP 2002518051 A5 JP2002518051 A5 JP 2002518051A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- motif
- fragment
- nucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002773 nucleotide Substances 0.000 description 17
- 239000003153 chemical reaction reagent Substances 0.000 description 14
- 230000001177 retroviral Effects 0.000 description 14
- 239000002253 acid Substances 0.000 description 13
- 125000003729 nucleotide group Chemical group 0.000 description 13
- 102100002940 ERVW-1 Human genes 0.000 description 8
- 101710027967 ERVW-1 Proteins 0.000 description 8
- 210000004940 Nucleus Anatomy 0.000 description 8
- 230000000295 complement Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 230000033228 biological regulation Effects 0.000 description 6
- 239000012472 biological sample Substances 0.000 description 6
- 230000000875 corresponding Effects 0.000 description 6
- 230000003831 deregulation Effects 0.000 description 6
- 230000014509 gene expression Effects 0.000 description 6
- 230000001575 pathological Effects 0.000 description 6
- 229920001850 Nucleic acid sequence Polymers 0.000 description 5
- 239000002299 complementary DNA Substances 0.000 description 5
- 150000007523 nucleic acids Chemical group 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 4
- -1 amino Chemical group 0.000 description 4
- IRSFLDGTOHBADP-UHFFFAOYSA-N embelin Chemical compound CCCCCCCCCCCC1=C(O)C(=O)C=C(O)C1=O IRSFLDGTOHBADP-UHFFFAOYSA-N 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- 206010003816 Autoimmune disease Diseases 0.000 description 3
- 229920002676 Complementary DNA Polymers 0.000 description 3
- 230000004075 alteration Effects 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000001363 autoimmune Effects 0.000 description 3
- 229920001405 Coding region Polymers 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- 241000713887 Human endogenous retrovirus Species 0.000 description 2
- 108020004999 Messenger RNA Proteins 0.000 description 2
- 102000004965 antibodies Human genes 0.000 description 2
- 108090001123 antibodies Proteins 0.000 description 2
- 201000009596 autoimmune hypersensitivity disease Diseases 0.000 description 2
- 108091006028 chimera Proteins 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000002163 immunogen Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 229920002106 messenger RNA Polymers 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 210000001519 tissues Anatomy 0.000 description 2
- 229960005486 vaccines Drugs 0.000 description 2
- 229920000160 (ribonucleotides)n+m Polymers 0.000 description 1
- RESSROXEVCGJLA-DFNTYYFDSA-N 99273-04-8 Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O)CC1=CC=CC=C1 RESSROXEVCGJLA-DFNTYYFDSA-N 0.000 description 1
- 210000004900 C-terminal fragment Anatomy 0.000 description 1
- 108010034572 CKS 17 Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108020004485 Nonsense Codon Proteins 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 229920000272 Oligonucleotide Polymers 0.000 description 1
- 241000658540 Ora Species 0.000 description 1
- 229940037201 Oris Drugs 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 241000711517 Torovirus Species 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cells Anatomy 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 229920003013 deoxyribonucleic acid Polymers 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 230000002068 genetic Effects 0.000 description 1
- 125000000267 glycino group Chemical group [H]N([*])C([H])([H])C(=O)O[H] 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 230000000626 neurodegenerative Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000002088 retrotransposition Effects 0.000 description 1
- 201000010874 syndrome Diseases 0.000 description 1
- 230000018412 transposition, RNA-mediated Effects 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9807920A FR2780069B1 (fr) | 1998-06-23 | 1998-06-23 | Famille de sequences nucleiques et de sequences proteiques deduites presentant des motifs retroviraux endogenes humains et leurs applications |
| FR98/07920 | 1998-06-23 | ||
| PCT/FR1999/001513 WO1999067395A1 (fr) | 1998-06-23 | 1999-06-23 | Famille de sequences nucleiques et de sequences proteiques deduites presentant des motifs retroviraux endogenes humains, et leurs applications |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002518051A JP2002518051A (ja) | 2002-06-25 |
| JP2002518051A5 true JP2002518051A5 (da) | 2006-07-20 |
Family
ID=9527737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000556036A Pending JP2002518051A (ja) | 1998-06-23 | 1999-06-23 | ヒト内因性レトロウイルスモチーフを有する核酸及び推定されるタンパク質配列のファミリーのならびにその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US6919438B1 (da) |
| EP (2) | EP1090122B1 (da) |
| JP (1) | JP2002518051A (da) |
| AU (1) | AU4375199A (da) |
| CA (1) | CA2331923C (da) |
| DE (1) | DE69939114D1 (da) |
| FR (1) | FR2780069B1 (da) |
| WO (1) | WO1999067395A1 (da) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2358385C (en) | 1998-12-31 | 2013-08-06 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| JP2003512844A (ja) * | 1999-10-28 | 2003-04-08 | ユニヴェルシテ・ドゥ・ジュネーブ | 多発性硬化症関連スーパー抗原 |
| FR2805279B1 (fr) * | 2000-02-23 | 2004-09-24 | Jean Jacques Guilhou | Sequences retrovirales associees a des affections cutanees |
| US20070249808A1 (en) * | 2000-10-30 | 2007-10-25 | Bernard Conrad | Multiple Sclerosis-related superantigen |
| EP1411770A4 (en) | 2001-07-05 | 2006-05-10 | Chiron Corp | POLYNUCLEOTIDES CODING FOR ANTIGENIC C-TYPE HIV POLYPEPTIDES, POLYPEPTIDES AND THEIR USE |
| AT411262B (de) | 2001-09-27 | 2003-11-25 | Wolff Klaus Dr | Humanes endogenes retrovirus |
| FR2865403B1 (fr) | 2004-01-23 | 2009-06-12 | Biomerieux Sa | Composition pour le traitement d'une pathologie associee a la msrv/herv-w |
| BRPI0509497B1 (pt) * | 2004-03-30 | 2022-07-19 | Institut Gustave Roussy | Seqüência de polipeptídeos envolvida na modulação do efeito imunosupressor de proteínas virais |
| WO2010030931A1 (en) * | 2008-09-11 | 2010-03-18 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Oligonucleotides targeting human endogenous retrovirus 9 (erv-9) long terminal repeat (ltr) and methods of use |
| US11351247B2 (en) | 2017-09-01 | 2022-06-07 | Inprother Aps | Vaccine for use in the prophylaxis and/or treatment of a disease |
| US20220088224A1 (en) | 2018-09-18 | 2022-03-24 | Vnv Newco Inc. | Arc-based capsids and uses thereof |
| CN110470837B (zh) * | 2019-08-30 | 2022-09-16 | 苏州西山生物技术有限公司 | 利用猴srv病毒gp20蛋白检测猴srv病毒的方法及其试剂盒 |
| US11129892B1 (en) | 2020-05-18 | 2021-09-28 | Vnv Newco Inc. | Vaccine compositions comprising endogenous Gag polypeptides |
| WO2023086882A1 (en) * | 2021-11-11 | 2023-05-19 | The Trustees Of The University Of Pennsylvania | Compositions and methods comprising car t cells comprising prdm1 and/or nr4a3 knockout |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5871996A (en) * | 1994-02-04 | 1999-02-16 | Bio Merieux | Retrovirus agents MSRV1 and MSRV2 associated with multiple sclerosis |
| FR2737500B1 (fr) | 1995-08-03 | 1997-08-29 | Bio Merieux | Materiel viral et fragments nucleotidiques associes a la sclerose en plaques, a des fins de diagnostic, prophylactiques et therapeutiques |
| US5708157A (en) * | 1996-07-26 | 1998-01-13 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
| US6312921B1 (en) * | 1996-07-26 | 2001-11-06 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
| CA2272845C (en) * | 1996-11-26 | 2010-01-12 | Bio Merieux | Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| ATE346153T1 (de) * | 1997-07-07 | 2006-12-15 | Bio Merieux | Endogene retrovirale sequenzen, verwandten mit auto-immune krankheiten oder mit schwangerschaftsstörungen |
| FR2765588A1 (fr) * | 1997-07-07 | 1999-01-08 | Bio Merieux | Materiel nucleique retroviral et fragments nucleotidiques notamment associes a la sclerose en plaques et/ou la polyarthrite rhumatoide, a des fins de diagnostic, prophylactiques et therapeutiques |
-
1998
- 1998-06-23 FR FR9807920A patent/FR2780069B1/fr not_active Expired - Lifetime
-
1999
- 1999-06-23 EP EP99926538A patent/EP1090122B1/fr not_active Expired - Lifetime
- 1999-06-23 AU AU43751/99A patent/AU4375199A/en not_active Abandoned
- 1999-06-23 US US09/719,554 patent/US6919438B1/en not_active Expired - Lifetime
- 1999-06-23 CA CA2331923A patent/CA2331923C/fr not_active Expired - Lifetime
- 1999-06-23 JP JP2000556036A patent/JP2002518051A/ja active Pending
- 1999-06-23 WO PCT/FR1999/001513 patent/WO1999067395A1/fr active IP Right Grant
- 1999-06-23 DE DE69939114T patent/DE69939114D1/de not_active Expired - Lifetime
- 1999-06-23 EP EP08010138A patent/EP1997895A1/fr not_active Withdrawn
-
2005
- 2005-01-05 US US11/028,539 patent/US7534439B2/en not_active Expired - Fee Related
-
2008
- 2008-12-17 US US12/336,813 patent/US20090263783A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rao et al. | Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome | |
| JP4723550B2 (ja) | 生存運動ニューロン（ｓｍｎ）遺伝子；脊髄筋萎縮 | |
| JP2009515524A5 (da) | ||
| Pulkkinen et al. | Identification of ABCC6 pseudogenes on human chromosome 16p: implications for mutation detection in pseudoxanthoma elasticum | |
| Albertella et al. | Characterization of a novel gene in the human major histocompatibility complex that encodes a potential new member of the I kappa B family of proteins | |
| JP2002518051A5 (da) | ||
| AU2003290715A1 (en) | Method for identifying risk of melanoma and treatments thereof | |
| EP0769053A2 (en) | Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of synovial sarcoma | |
| Schmitt et al. | Genomic structure, chromosomal localization, and expression pattern of the human LIM-homeobox3 (LHX 3) gene | |
| US20020142003A1 (en) | Tumor-associated antigen (B345) | |
| CA2461199A1 (en) | Atlastin | |
| WO1998007748A2 (en) | Plag gene family and tumorigenesis | |
| CN113234134B (zh) | 一种远端关节挛缩综合症致病基因myh3及其用途 | |
| EP1352092B1 (en) | Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis | |
| CN110592198A (zh) | 高灵敏度检测flt3/d835y基因突变的方法、系统和试剂盒 | |
| Nobile et al. | Identification and characterization of a novel human brain-specific gene, homologous to S. scrofa tmp83. 5, in the chromosome 10q24 critical region for temporal lobe epilepsy and spastic paraplegia | |
| KR102565803B1 (ko) | 고혈압에 대한 정보 제공 방법 및 이를 이용한 키트 | |
| US20100055709A1 (en) | Tubulin Mutation Diagnostic | |
| AU2002224781A1 (en) | Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis | |
| WO1998006871A1 (en) | Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of papillary renal cell carcinoma | |
| CN117165609A (zh) | 一种cbfa2t3-nat16融合基因及其检测引物和应用 | |
| MXPA01012717A (es) | Expresion genica modulada en inflamacion gastrointestinal. | |
| CN110714081A (zh) | 定量检测oc-stamp基因表达水平的成套试剂及其应用 | |
| WO2002064831A2 (en) | Single nucelotide polymorphisms of the seek1 gene associated withpsoriasis | |
| JP2006121961A (ja) | 顎骨骨幹異形成症ｇｄｄの原因遺伝子ｇｄｄ１とその用途 |